PCSK9 Inhibitors

Category for reagents and intermediates used in the synthesis or analysis of PCSK9 inhibitors, which target proprotein convertase subtilisin/kexin type 9 to regulate cholesterol metabolism.
bubble_chart REAGENT
Alirocumab
≥95%,75 mg/mL
tagCAS:1245916-14-6
functionsFormula:C₆₄₇₂H₉₉₉₆N₁₇₃₆O₂₀₃₂S₄₂
gavelMW:146 kDa g/mol
฿47,570.00
View
bubble_chart REAGENT
Evolocumab
≥95%
tagCAS:1256937-27-5
฿106,090.00
View
bubble_chart REAGENT
Alirocumab
≥95%
tagCAS:1245916-14-6
functionsFormula:C₆₄₇₂H₉₉₉₆N₁₇₃₆O₂₀₃₂S₄₂
gavelMW:146 kDa g/mol
฿53,400.00
View

Cart

No products

Subtotal: 0.00
Total 0.00 THB